Tgfβ1-expression is known to be associated with podocyte damage by the stimulation of extracellular matrix accumulation [30], while estrogen supplementation was shown to prevent Tgfβ1 mediated glomerulopathy [31]. The gene discussed is TGFB1; the disease is lipoprotein glomerulopathy.